Human papillomaviruses (HPVs) were detected in 69 (43.7%) of 158 and in 7 (4.5%) of 155 anogenital hairs obtained from 53 patients with genital warts (GWs) and from 53 age-matched healthy control subjects, respectively. At least 1 hair sample was positive for 69.8% of patients and for 13.2% of control subjects. For patients, HPV was detected in 64.2%, 39.6%, and 26.9% of hairs plucked from the pubic, scrotal, and perianal regions, respectively. For 91.9% of patients, the same HPV genotype was identified in GWs and hairs from at least 1 sampling site. Having GWs was found to be strongly associated with the presence in anogenital hairs of the HPV genotype causing the GWs (range of odds ratios, 13.0 -20.0).
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Genital warts (GWs)-which typically present as flesh-colored exophytic lesions on the external genitalia, including the penis, vulva, scrotum, perineum, and perianal skin-are the most common benign tumors in the anogenital region [1] . A recent study of almost 70,000 women in the 4 Nordic countries showed that 10% developed GWs before the age of 45 years [2] . In the United States, a national survey of almost 9000 sexually active men and women showed that 5.6% of 18 -59-year-olds reported having received a diagnosis of GWs [1] . GWs are not lifethreatening, but these lesions can cause such clinical symptoms as burning, itching, bleeding, and pain and can provoke psychosocial stress, resulting in lowered self-esteem, shame, and embarrassment [1, 2] .
Several studies have shown that virtually all GWs are etiologically associated with human papillomaviruses (HPVs) [3] [4] [5] . HPV-6 and -11 are the 2 most frequently detected HPV genotypes, accounting for 80%-96.4% of GWs, but at least 25 other alpha-HPV genotypes have been found in GWs [3] [4] [5] [6] .
The clinical prognosis for GWs differs from person to person, varying from short-term spontaneous regression to long-term persistence and recurrence. Although most GWs will spontaneously resolve, therapy is often preferred to avoid the psychosocial and psychosexual concerns associated with a slow regression process [3] . The efficacy of all therapeutic options is less than optimal, and multiple treatments are often necessary for complete resolution. Also, GWs frequently reoccur irrespective of the treatment method used and the location of the lesions. Several mechanisms have been proposed to explain the recurrence of GWs after therapy or the reappearance of GWs in nontreated patients. Because epithelium of healthy appearance surrounding GWs might be subclinically infected with HPV up to 1.0 cm from the source lesion [7] , it might serve as a reservoir for the recurrence or reappearance of GWs. Inadequate treatment (e.g., partial removal of GWs) can also cause recurrence. A pilot study published in 1999 by Boxman et al. [8] proposed that hair follicles in the vicinity of GWs could be an endogenous HPV reservoir that may play a role in the recurrence of GWs. However, the study group was relatively small and heterogeneous and included immunocompromised patients, and no control subjects were analyzed. To overcome these problems, we comparatively investigated the presence and distribution of alpha-HPV in hairs plucked from 3 different sites in the anogenital region for a representative group of male patients with GWs and for a control group of age-matched subjects. Both groups were enrolled from our previous studies of beta-HPV in hairs plucked from different body sites [9, 10] .
Methods. The first study group consisted of 53 male Slovenian patients with clinically evident and histologically confirmed GWs (age range, 17-36 years; mean age, 28.7 years) [5] . Patients were required to have at least 5 exophytic GWs on the glans of penis, coronal sulcus, or foreskin. For each patient, 2 GW samples were obtained by excision biopsy, and 5 hairs per sampling location were plucked from 3 different sites in the anogenital region (scrotal, pubic, and perianal regions). A disposable pair of sterile tweezers and gloves were used for each individual. The second study group (control subjects) consisted of 53 healthy male volunteers (age range, 17-36 years; mean age, 27.2 years) who individually matched the patients in age within 2 years [10] . All control subjects denied the presence of any kind of warts in the past as well as among their sex partners, and all reported previous sexual intercourse. For each control subject, 5 hairs per sampling location were plucked from the scrotal, pubic, and perianal regions.
Only plucked hairs that contained follicles were collected for both study groups. A detailed clinical examination and a careful review of the medical history showed the absence of any apparent immune system deficiency in all 106 individuals enrolled. All individuals included in the study tested negative for antibody to HIV. The study was approved by the Medical Ethics Committee of the Slovenian Ministry of Health, and written informed consent was provided by all participants.
DNA was extracted from GW samples and plucked hairs as described elsewhere [5] . For detection of alpha-HPV, polymerase chain reaction (PCR) was performed on all samples with the primers PGMY09/11 and CPI/IIg, which target 450-bp and 188-bp fragments of the L1 and E2 genes, respectively [5, 11, 12] . HPV genotypes were determined by restriction fragment-length polymorphism analysis of the PGMY09/11 PCR products or by sequencing the CPI/CPIIg PCR products [5, 9, 13] . For samples in which Ͼ1 HPV genotype was detected, genotyping results were confirmed using the Linear Array HPV Genotyping Test (Roche Diagnostics) [5, 9] .
The sequence diversity of selected HPV-6 isolates was investigated within the E2 and E5a genes. Amplified PCR products were sequenced directly, and sequences were analyzed using BioEdit software (version 7.0.9.0; North Carolina State University) [14] .
Data were analyzed using SPSS for Windows (version 15.0.0). McNemar's exact test was used to compare paired proportions. P values were 2-sided, and differences were considered statistically significant at P Ͻ .05.
Results. A total of 53 GW samples and 318 plucked hair samples (53 samples each from the scrotal, pubic, and perianal regions of the patients and healthy control subjects) were collected. The 536-bp fragment of the ␤-globin gene was amplified successfully from all 53 GW samples and from 313 (98.4%) of 318 hair samples. Because of negative results for internal control amplification, 5 samples (1 and 4 samples obtained from patients and control subjects, respectively) were excluded from further study.
The results of detection and genotyping of alpha-HPV in GW samples and corresponding plucked anogenital hair samples by means of a combination of 3 PCR-based methods are summarized in table 1. Alpha-HPV genotypes were detected in all 53 GW samples and in 69 (43.7%) of 158 hair samples obtained from patients with GWs. Infection with a single HPV genotype was found in 56 hair samples, and infection with multiple HPV genotypes was found in 13 hair samples. Fifteen different alpha-HPV genotypes were detected in hair samples: HPV-6 was found most often (71.0%), followed by HPV-11 (15.9%) and HPV-18 (8.7%). Alpha-HPV was detected in 34 (64.2%) of 53, 21 (39.6%) of 53, and 14 (26.9%) of 52 hairs plucked from the pubic, scrotal, and perianal regions, respectively. The prevalence of alpha-HPV in pubic hairs was significantly higher than that in scrotal and perianal hairs (P ϭ .002 and P Ͻ .001, respectively), whereas the difference in prevalence between scrotal and perianal hairs was not statistically significant (P ϭ .146). HPV DNA was detected in at least 1 hair sampling site for 37 (69.8%) of 53 patients with GWs. The same HPV genotype was identified in the GW sample and in hairs plucked from at least 1 sampling site for 34 (91.9%) of 37 patients with HPV-positive hair samples. Eight, 11, and 15 patients had the same HPV genotype in GW samples and in hairs plucked from all 3, from 2, and from 1 sampling site, respectively. Sequence comparison of HPV-6 isolates obtained from 4 patients harboring HPV-6 in GWs and in hairs plucked from all 3 sampling sites (patients 1, 2, 20, and 22) (table 1) clearly showed that each patient was infected with a single and unique HPV-6 genomic variant ( figure 1) .
In contrast to the findings for patients with GWs, only 7 (4.5%) of 155 hairs plucked from 7 control subjects contained alpha-HPV. All 7 hair samples contained a single HPV genotype. HPV-6 was detected in 2 samples, and HPV-10, -16, -31, -54, and -58 were detected in a single sample each. In control subjects, alpha-HPV was detected in 4 (7.5%) of 53, 2 (3.8%) of 52, and 1 (2.0%) of 50 hairs plucked from the pubic, scrotal, and perianal regions, respectively. Having GWs was found to be strongly associated with the presence of a GW-causing HPV genotype in anogenital hairs in the pubic (odds ratio Discussion. In the first comparative study of alpha-HPV in anogenital hairs plucked from male patients with GWs and from age-matched healthy control subjects, we have clearly shown that hair follicles are an important endogenous reservoir of alpha-HPV in the anogenital region. To the best of our knowledge, the presence of alpha-HPV in anogenital hairs has been studied previously only in a pilot study [8] , which included a heterogeneous population consisting of 25 patients with GWs (16 males and 9 females), and the presence of alpha-HPV DNA was detected in 9 (36%) of 25 pubic hair samples and in 11 (50%) of 22 perianal hair samples. The majority of HPV-positive hair samples contained HPV-6 or -11. Our study confirmed the results of the pilot study and added several important novel findings. Because of the inclusion of a larger, representative, homogeneous group of patients with GWs and of a control group, we were able to determine the "background" prevalence of alpha-HPV in apparently normal skin and, thus, to elucidate more reliably the significance of the presence of HPV DNA in anogenital hairs obtained from patients with GWs. Our study showed that, in comparison to healthy individuals, who only occasionally harbor alpha-HPV in anogenital hairs, more than two-thirds of patients with GWs also had alpha-HPV in their anogenital hairs. In a particular patient, the HPV present in anogenital hairs matched that present in GWs not only on the genotype level (91.9%) but also on the subgenotype level, suggesting a very close association between HPV strains present in GWs and in corresponding anogenital hairs (figure 1).
In hairs plucked from patients with GWs, the prevalence of alpha-HPV declined significantly with distance from the GW (from 64.2% in the pubic to 29.6% in the perianal region). This finding and the exact matching of sequences of HPV-6 isolates from GWs and hairs in a particular patient (figure 1) suggest that the GW is the most probable source of HPV detected in anogenital hairs. Anogenital hairs probably become infected either by direct physical contact with the highly infective surface of GWs or by indirect means (e.g., via the hands, fomites, or vaginal secretions of a female sex partner). Our previous study [9] showed that alpha-HPV can occasionally be found in the eyebrow hairs of patients with GWs, indicating that means of transmission other than direct physical contact with GWs could be involved in the spreading of an HPV infection from GWs to other parts of the body. To confirm this, we compared sequences of HPV-6 detected in eyebrow hair samples from a patient who was included in both the previous and the present study (patient 1) (table 1) with sequences of HPV-6 obtained from his GWs and hair samples obtained from all 3 anogenital sites and found that all 5 sequences were identical (data not shown).
Although the present data strongly indicate that anogenital hairs are an important reservoir of alpha-HPV in patients with GWs, some important limitations of our study should be highlighted. Because no tissue samples were obtained from control subjects, it is possible that some of these subjects were misclassified because of inapparent GWs. No penile, scrotal, or other anogenital swab samples were collected from patients with GWs, so it is possible that, in addition to anogenital hairs, other sites are a reservoir of HPV in the anogenital area. The sampling of Ͼ5 hairs per location could increase the sensitivity of HPV detection. Last, because the study was performed in males only, whether our findings can be generalized to females or other populations remains an open question.
Although we have undoubtedly confirmed a close association between GWs and the presence of HPV in anogenital hairs, the duration of HPV persistence in anogenital hairs and the ability of the HPV present in hairs to cause the reappearance of GWs remain unresolved. Boxman et al. [8] showed in 2 patients and Adachi et al. [15] showed in a single patient that HPV can be detected in anogenital hairs even after successful treatment of GWs. To fully understand the consequences of our findings and confirm the encouraging results of pilot studies, a long-term prospective cohort study with frequent monitoring of HPV DNA in anogenital hairs after both successful and unsuccessful treatment of GWs is needed. Such a study may help to elucidate the mechanism of recurrence and reappearance of GWs, increase our understanding of the routes and dynamics of low-risk alpha-HPV transmission, and improve the currently used prevention measures.
